Replies to post #190848 on Biotech Values

[DewDiligence]

TBRA thinks phase-2 CENTAUR study could lead to an application for FDA accelerated approval in NASH based on 1-year data:

https://www.clinicaltrials.gov/ct2/show/NCT02217475

1-year data for primary endpoint is expected in Jun 2014, according to the above listing.